Tenaya Therapeutics annual return on equity
2021
2022
2023
2024
2025
Tenaya Therapeutics Return on Equity (ROE) Growth & History (TNYA)
Tenaya Therapeutics's return on equity was −83.84% for fiscal 2025.
View full Tenaya Therapeutics company overviewTenaya Therapeutics annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −83.84% | +11.85 pp |
| 2024 | 2024-12-31 | −95.69% | −30.86 pp |
| 2023 | 2023-12-31 | −64.83% | −17.44 pp |
| 2022 | 2022-12-31 | −47.39% | +26.36 pp |
| 2021 | 2021-12-31 | −73.75% | — |
Tenaya Therapeutics quarterly return on equity
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −49.42% | −28.18 pp |
| Q1 2026 | 2026-03-31 | −16.80% | +8.52 pp |
| Q4 2025 | 2025-12-31 | −19.57% | +3.63 pp |
| Q3 2025 | 2025-09-30 | −22.20% | −1.41 pp |
| Q2 2025 | 2025-06-30 | −21.24% | −1.10 pp |
| Q1 2025 | 2025-03-31 | −25.31% | −3.66 pp |
| Q4 2024 | 2024-12-31 | −23.20% | −3.53 pp |
| Q3 2024 | 2024-09-30 | −20.79% | −4.36 pp |
| Q2 2024 | 2024-06-30 | −20.15% | −3.73 pp |
| Q1 2024 | 2024-03-31 | −21.66% | −7.82 pp |
| Q4 2023 | 2023-12-31 | −19.67% | −4.43 pp |
| Q3 2023 | 2023-09-30 | −16.43% | −1.82 pp |
| Q2 2023 | 2023-06-30 | −16.41% | −4.41 pp |
| Q1 2023 | 2023-03-31 | −13.84% | −2.06 pp |
| Q4 2022 | 2022-12-31 | −15.24% | −6.26 pp |
| Q3 2022 | 2022-09-30 | −14.61% | +4.10 pp |
| Q2 2022 | 2022-06-30 | −12.01% | — |
| Q1 2022 | 2022-03-31 | −11.77% | — |
| Q4 2021 | 2021-12-31 | −8.98% | — |
| Q3 2021 | 2021-09-30 | −18.71% | — |
Tenaya Therapeutics return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Tenaya Therapeutics's return on equity decreased from −73.75% to −83.84%, a change of −10.09 percentage points. The latest reported quarter, Q2 2026, shows −49.42%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tenaya Therapeutics source filings ↗